Clinical Trial Update: SPP100 Dose Finding Study in Japan [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of SPP100 in Japan for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• SPP100

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 2 | Status: COMPLETED